31 employees
Human Immunology Biosciences is a biotechnology company focused on developing therapies for immune-mediated diseases.
2021
$120M
from 3 investors over 3 rounds
HIBio raised $120M on November 1, 2022
Investors: Monograph Capital, ARCH Venture Partners and JEITO